Christopher Austin makes his return to industry, jumping ship from NIH over to CEO-partner role at Flagship
Flagship Pioneering has plucked its latest hire straight from the ranks of the NIH.
After nearly two decades at the NIH and almost 10 years as founding director of the National Center for Advancing Translational Sciences (NCATS), Christopher Austin is packing his bags for Cambridge, MA. There he’ll become Flagship’s newest CEO-partner — an esteemed role that the VC has been testing for the last year or so.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.